Growth hormone corrects vascular dysfunction in patients with chronic heart failure
- 17 December 2001
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 39 (1) , 90-95
- https://doi.org/10.1016/s0735-1097(01)01707-7
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Endothelial Dysfunction: Does It Matter? Is It Reversible?Journal of the American College of Cardiology, 1997
- Mechanisms and implications of endothelial dysfunction in congestive heart failureCurrent Opinion in Cardiology, 1997
- Growth hormone and heart performance: A novel mechanism of cardiac wall stress regulation in humansEuropean Heart Journal, 1997
- Endothelial dysfunction: Clinical implicationsProgress in Cardiovascular Diseases, 1997
- Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled study.Journal of Clinical Investigation, 1996
- Exercise-induced vasodilation in forearm circulation of normal subjects and patients with congestive heart failure: Role of endothelium-derived nitric oxideJournal of the American College of Cardiology, 1996
- Randomized, Double-Blind, Placebo-Controlled Study of Supplemental Oral l -Arginine in Patients With Heart FailureCirculation, 1996
- Effects of L-arginine on impaired acetylcholine-induced and ischemic vasodilation of the forearm in patients with heart failure.Circulation, 1994
- Endothelial function in chronic congestive heart failureThe American Journal of Cardiology, 1992
- Endothelium-dependent vasodilation is attenuated in patients with heart failure.Circulation, 1991